2009
DOI: 10.1111/j.1747-0285.2009.00832.x
|View full text |Cite
|
Sign up to set email alerts
|

On the Origins of Enzyme Inhibitor Selectivity and Promiscuity: A Case Study of Protein Kinase Binding to Staurosporine

Abstract: Relationships between ligand binding and the shapes of the binding sites in families of homologous enzymes are investigated by comparing matrices of distances between key binding site atoms. Multiple linear regression is used to help identify key distances that influence ligand binding affinity. In order to illustrate the utility of this generic approach, we study protein kinase binding sites for ATP and the promiscuous competitive inhibitor, staurosporine. We show that the size of the gatekeeper residue and t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
71
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 83 publications
(76 citation statements)
references
References 32 publications
4
71
0
Order By: Relevance
“…22,29,44 To examine whether interaction with any of these targets might account for the induction of Mcl-1 down-regulation by roscovitine or CR8, we made use of a series of selective pharmacological inhibitors of these kinases (none of these inhibit CDKs) ( Figure 4 49 ). In contrast to a general kinase inhibitor (staurosporine 50 ), roscovitine, and CR8, none of these inhibitors induced Mcl-1 down-regulation. N6-methyl-roscovitine, a kinase inactive derivative of roscovitine, 51 was unable to trigger Mcl-1 down-regulation.…”
Section: Mcl-1 Down-regulation Is Associated With Inhibition Of Cdksmentioning
confidence: 76%
“…22,29,44 To examine whether interaction with any of these targets might account for the induction of Mcl-1 down-regulation by roscovitine or CR8, we made use of a series of selective pharmacological inhibitors of these kinases (none of these inhibit CDKs) ( Figure 4 49 ). In contrast to a general kinase inhibitor (staurosporine 50 ), roscovitine, and CR8, none of these inhibitors induced Mcl-1 down-regulation. N6-methyl-roscovitine, a kinase inactive derivative of roscovitine, 51 was unable to trigger Mcl-1 down-regulation.…”
Section: Mcl-1 Down-regulation Is Associated With Inhibition Of Cdksmentioning
confidence: 76%
“…However, amino acids some distance away can also be under restraint, particularly from the need to maintain precise arrangements of catalytic residues and cofactor-binding interactions. Conversely, amino acid substitutions may affect substrateand drug-binding specificity, a factor evident in the analysis of kinase drugs (Figure 4) [29].…”
Section: Resultsmentioning
confidence: 99%
“…Mutation of the gatekeeper residue usually causes minimal change in kinase activity (47) but might confer resistance to inhibitors. The size of the gatekeeper residue has been correlated with the binding affinity for staurosporine (51). The group of kinases with larger gatekeeper residues (e.g.…”
Section: Discussionmentioning
confidence: 99%